BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28205381)

  • 21. MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study.
    Zhang M; Wong SW; Wright JN; Wagner MW; Toescu S; Han M; Tam LT; Zhou Q; Ahmadian SS; Shpanskaya K; Lummus S; Lai H; Eghbal A; Radmanesh A; Nemelka J; Harward S; Malinzak M; Laughlin S; Perreault S; Braun KRM; Lober RM; Cho YJ; Ertl-Wagner B; Ho CY; Mankad K; Vogel H; Cheshier SH; Jacques TS; Aquilina K; Fisher PG; Taylor M; Poussaint T; Vitanza NA; Grant GA; Pfister S; Thompson E; Jaju A; Ramaswamy V; Yeom KW
    Radiology; 2022 Aug; 304(2):406-416. PubMed ID: 35438562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative evaluation for disseminated medulloblastoma involving the spine: contrast-enhanced MR findings, CSF cytologic analysis, timing of disease occurrence, and patient outcomes.
    Meyers SP; Wildenhain SL; Chang JK; Bourekas EC; Beattie PF; Korones DN; Davis D; Pollack IF; Zimmerman RA
    AJNR Am J Neuroradiol; 2000 Oct; 21(9):1757-65. PubMed ID: 11039362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas.
    Lee C; Lee J; Choi SA; Kim SK; Wang KC; Park SH; Kim SH; Lee JY; Phi JH
    BMC Cancer; 2018 May; 18(1):535. PubMed ID: 29739450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myelography in patients with medulloblastoma.
    Deutsch M; Scotti LN; Hardman DR; Reigel DH; Scarff TB
    Radiology; 1975 Nov; 117(2):467-8. PubMed ID: 1178883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastoma.
    Dasgupta A; Gupta T; Maitre M; Kalra B; Chatterjee A; Krishnatry R; Goda JS; Shirsat N; Epari S; Sahay A; Janu A; Pungavkar S; Chinnaswamy G; Patil V; Moiyadi A; Shetty P; Jalali R
    Strahlenther Onkol; 2022 Mar; 198(3):291-303. PubMed ID: 35059761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
    Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medulloblastoma in adults : A retrospective single institution analysis.
    Hadi I; Roengvoraphoj O; Niyazi M; Roeder F; Schüller U; Belka C; Nachbichler SB
    Strahlenther Onkol; 2018 Mar; 194(3):225-234. PubMed ID: 29147840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI Characteristics of Primary Tumors and Metastatic Lesions in Molecular Subgroups of Pediatric Medulloblastoma: A Single-Center Study.
    Mata-Mbemba D; Zapotocky M; Laughlin S; Taylor MD; Ramaswamy V; Raybaud C
    AJNR Am J Neuroradiol; 2018 May; 39(5):949-955. PubMed ID: 29545246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II study of radioimmunotherapy with intraventricular
    Kramer K; Pandit-Taskar N; Humm JL; Zanzonico PB; Haque S; Dunkel IJ; Wolden SL; Donzelli M; Goldman DA; Lewis JS; Lyashchenko SK; Khakoo Y; Carrasquillo JA; Souweidane MM; Greenfield JP; Lyden D; De Braganca KD; Gilheeney SW; Larson SM; Cheung NV
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28940863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical Treatment of Intramedullary Spinal Metastasis in Medulloblastoma: Case Report and Review of the Literature.
    Goyal A; Cajigas I; Ibrahim GM; Brathwaite CD; Khatib Z; Niazi T; Bhatia S; Ragheb J
    World Neurosurg; 2018 Oct; 118():42-46. PubMed ID: 29990605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic significance of postoperative residual contrast enhancement on CT scan in pediatric patients with medulloblastoma.
    Bourne JP; Geyer R; Berger M; Griffin B; Milstein J
    J Neurooncol; 1992 Nov; 14(3):263-70. PubMed ID: 1460489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours.
    Łastowska M; Jurkiewicz E; Trubicka J; Daszkiewicz P; Drogosiewicz M; Malczyk K; Grajkowska W; Matyja E; Cukrowska B; Pronicki M; Perek-Polnik M; Perek D; Dembowska-Bagińska B
    J Neurooncol; 2015 May; 123(1):65-73. PubMed ID: 25862008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication.
    Weil AG; Wang AC; Westwick HJ; Ibrahim GM; Ariani RT; Crevier L; Perreault S; Davidson T; Tseng CH; Fallah A
    J Neurooncol; 2017 Mar; 132(1):99-107. PubMed ID: 27981412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cranial-spinal junction in medulloblastoma: does it matter?
    Narayana A; Jeswani S; Paulino AC
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):81-4. PubMed ID: 10219798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
    Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
    J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study.
    Wahba HA; Abu-Hegazy M; Wasel Y; Ismail EI; Zidan AS
    J BUON; 2013; 18(2):425-9. PubMed ID: 23818356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myelography for staging medulloblastoma.
    Deutsch M; Laurent JP; Cohen ME
    Cancer; 1985 Oct; 56(7 Suppl):1763-6. PubMed ID: 4027907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
    Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
    Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
    Massimino M; Antonelli M; Gandola L; Miceli R; Pollo B; Biassoni V; Schiavello E; Buttarelli FR; Spreafico F; Collini P; Giangaspero F
    Pediatr Blood Cancer; 2013 Feb; 60(2):210-6. PubMed ID: 22693015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of myelography in the management of childhood medulloblastoma.
    Deutsch M; Reigel DH
    Cancer; 1980 Apr; 45(8):2194-7. PubMed ID: 7370959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.